Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 8.31 USD 2.59% Market Closed
Market Cap: 467.9m USD

Wall Street
Price Targets

ZVRA Price Targets Summary
Zevra Therapeutics Inc

Wall Street analysts forecast ZVRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZVRA is 23.31 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

Lowest
Price Target
18.18 USD
119% Upside
Average
Price Target
23.31 USD
181% Upside
Highest
Price Target
27.3 USD
229% Upside
Zevra Therapeutics Inc Competitors:
Price Targets
HYPE3
Hypera SA
32% Upside
APLLTD
Alembic Pharmaceuticals Ltd
23% Upside
ORNBV
Orion Oyj
11% Upside
AJANTPHARM
Ajanta Pharma Ltd
17% Upside
002653
Haisco Pharmaceutical Group Co Ltd
82% Upside

Revenue
Forecast

Revenue Estimate
Zevra Therapeutics Inc

The compound annual growth rate of Zevra Therapeutics Inc's revenue for the next 4 years is 90%.

N/A
Past Growth
90%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Zevra Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Zevra Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-94%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZVRA's stock price target?
Price Target
23.31 USD

According to Wall Street analysts, the average 1-year price target for ZVRA is 23.31 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

What is Zevra Therapeutics Inc's Revenue forecast?
Projected CAGR
90%

The compound annual growth rate of Zevra Therapeutics Inc's revenue for the next 4 years is 90%.

Back to Top